Pointe-Claire, Canada

John J Bergeron

This inventor holds 1 USPTO granted patent. Top assignee: National Research Council of Canada. Active years: 1997.

IDiyas Innovation Intelligence. (2026). Inventor Profile: John J Bergeron. Retrieved from https://idiyas.com/inventor/john-j-bergeron

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 11(Granted Patents)


Company Filing History:


Years Active: 1997

Loading Chart...
1 patent (USPTO):Explore Patents

Title: John J Bergeron: Innovator in Protein Trafficking Disorders

Introduction

John J Bergeron is a notable inventor based in Pointe-Claire, Canada. He has made significant contributions to the field of protein trafficking disorders through his innovative research and patents. His work focuses on enhancing secretory protein production and developing methods for diagnosing and treating related disorders.

Latest Patents

John J Bergeron holds a patent for "Methods of detection and treatment of protein trafficking disorders." This invention provides compositions and methods aimed at increasing secretory protein production. Additionally, it offers compositions for treating and diagnosing protein trafficking disorders by altering calnexin activity to enhance protein secretion or retention. He has 1 patent to his name.

Career Highlights

John J Bergeron is affiliated with the National Research Council of Canada, where he conducts his research. His work has been instrumental in advancing the understanding of protein trafficking and its implications for various medical conditions.

Collaborations

Throughout his career, John has collaborated with esteemed colleagues, including David Y Thomas and Ikuo Wada. These partnerships have contributed to the depth and breadth of his research in the field.

Conclusion

John J Bergeron is a pioneering inventor whose work in protein trafficking disorders has the potential to impact medical treatments significantly. His innovative approaches and collaborations continue to advance the field of biotechnology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…